Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
为什么 Avenue Therapeutics 的股价飙升了约 106%；以下是昨天以来的 87 个最大
Gainers
赢家
Spero Therapeutics, Inc. (NASDAQ:SPRO) shares jumped 167.7% to close at $2.20 on Thursday after the company announced it has entered into an exclusive license agreement with GSK for Spero's late-stage antibiotic asset, tebipenem HBr. Spero Therapeutics will receive $66 million upfront, with potential for future milestone payments, and tiered royalties.
Avenue Therapeutics, Inc. (NASDAQ:ATXI) gained 105.9% to close at $0.44 after the company received meeting minutes from the FDA regarding a meeting conducted on August 9, 2022, for IV Tramadol. The company also announced the effectiveness of its 1-for-15 reverse split on Sept. 23.
Panbela Therapeutics, Inc. (NASDAQ:PBLA) gained 46.4% to close at...
Spero治疗公司纳斯达克(SPRO：SPRO)股价周四大涨167.7%，收于2.2美元，此前该公司宣布已与葛兰素史克就斯培罗的晚期抗生素资产泰比培南HBR达成独家许可协议。Spero Treate...
登录免费看全文
登录/注册
资讯热榜
更新时间